Parallel Industries Inc. (EAPH) Research

Currently, Parallel Industries Inc. does not conduct substantial business operations. Historically, the company was involved in developing and commercializing various topically applied medications to treat cancer, alongside other therapeutic solutions for a range of medical conditions. Its strategic emphasis has typically covered the entire pharmaceutical process: from development and licensing to manufacturing and marketing of both prescription and over-the-counter products. Established in 1997, the firm is headquartered in Toronto, Canada, and was formerly known as Easton Pharmaceuticals Inc. before rebranding as Parallel Industries Inc. in December 2020.

Market snapshot

Symbol
EAPH
Price
$0.00
Day change
0.00%
Market cap
$18.7K
P/E ratio
-0.14x
52-week range
0.000001-0.00002
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Advantis Corp. (ADVT)
  • Black Bird Biotech, Inc. (BBBT)
  • CannLabs, Inc. (CANL)
  • The Greater Cannabis Company, Inc. (GCAN)
  • Green Rain Energy Holdings Inc. (GREH)
  • Panbela Therapeutics, Inc. (PBLA)
  • Street Capital Inc. (REZNF)
  • Transnational Cannabis Ltd. (TRCNF)

Open Parallel Industries Inc. (EAPH) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.